-
1
-
-
80052599925
-
Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data
-
Oitate, M., Masubuchi, N., Ito, T., Yabe, Y., Karibe, T., Aoki, T., Murayama, N., Kurihara, A., Okudaira, N. and Izumi, T.: Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data. Drug Metab. Pharmacokinet., 26:423-430 (2011).
-
(2011)
Drug Metab. Pharmacokinet
, vol.26
, pp. 423-430
-
-
Oitate, M.1
Masubuchi, N.2
Ito, T.3
Yabe, Y.4
Karibe, T.5
Aoki, T.6
Murayama, N.7
Kurihara, A.8
Okudaira, N.9
Izumi, T.10
-
2
-
-
71449090902
-
Interspecies scaling of therapeutic monoclonal antibodies: Initial look
-
Ling, J., Zhou, H., Jiao, Q. and Davis, H. M.: Interspecies scaling of therapeutic monoclonal antibodies: initial look. J. Clin. Pharmacol., 49: 1382-1402(2009).
-
(2009)
J. Clin. Pharmacol
, vol.49
, pp. 1382-1402
-
-
Ling, J.1
Zhou, H.2
Jiao, Q.3
Davis, H.M.4
-
3
-
-
78651400009
-
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: What have we learned?
-
Deng, R., Iyer, S., Theil, F. P., Mortensen, D. L., Fielder, P. J. and Prabhu, S.: Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: What have we learned? MAbs., 3: 61-66 (2011).
-
(2011)
MAbs
, vol.3
, pp. 61-66
-
-
Deng, R.1
Iyer, S.2
Theil, F.P.3
Mortensen, D.L.4
Fielder, P.J.5
Prabhu, S.6
-
5
-
-
0021010984
-
Interspecies pharmacokinetic scaling and the Dedrick plots
-
Boxenbaum, H. and Ronfeld, R.: Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol., 245: R768-R775 (1983).
-
(1983)
Am. J. Physiol
, vol.245
-
-
Boxenbaum, H.1
Ronfeld, R.2
-
6
-
-
0021703938
-
Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm
-
Boxenbaum, H.: Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab. Rev., 15: 1071-1121 (1984).
-
(1984)
Drug Metab. Rev
, vol.15
, pp. 1071-1121
-
-
Boxenbaum, H.1
-
7
-
-
84872830556
-
-
Adalimumab (Humira) New Drug Application [NDA]. Available at the website of PMDA (Pharmaceuticals and Medical Devices Agency)
-
Adalimumab (Humira) New Drug Application [NDA]. Available at the website of PMDA (Pharmaceuticals and Medical Devices Agency): http://www.info.pmda.go.jp/shinyaku/P200800019/index.html.
-
-
-
-
8
-
-
33646827589
-
Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: Pharmacokinetic, pharmacodynamic, and toxicologic effects
-
Halpern, W. G., Lappin, P., Zanardi, T., Cai, W., Corcoran, M., Zhong, J. and Baker, K. P.: Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects. Toxicol. Sci., 91: 586-599 (2006).
-
(2006)
Toxicol. Sci
, vol.91
, pp. 586-599
-
-
Halpern, W.G.1
Lappin, P.2
Zanardi, T.3
Cai, W.4
Corcoran, M.5
Zhong, J.6
Baker, K.P.7
-
9
-
-
54349100000
-
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: A phase I trial in patients with systemic lupus erythematosus
-
Furie, R., Stohl, W., Ginzler, E. M., Becker, M., Mishra, N., Chatham, W., Merrill, J. T., Weinstein, A., McCune, W. J., Zhong, J., Cai, W. and Freimuth, W.: Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res. Ther., 10: R109 (2008).
-
(2008)
Arthritis Res. Ther
, vol.10
-
-
Furie, R.1
Stohl, W.2
Ginzler, E.M.3
Becker, M.4
Mishra, N.5
Chatham, W.6
Merrill, J.T.7
Weinstein, A.8
McCune, W.J.9
Zhong, J.10
Cai, W.11
Freimuth, W.12
-
10
-
-
85031181113
-
-
Bevacizumab (Avastin) NDA: Available at the website of PMDA
-
Bevacizumab (Avastin) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200700027/index.html.
-
-
-
-
11
-
-
85031181104
-
-
Etanercept (Enbrel) NDA: Available at the website of PMDA
-
Etanercept (Enbrel) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200500002/index.html.
-
-
-
-
12
-
-
85031189519
-
-
Infliximab (Remicade) NDA: Available at the website of PMDA
-
Infliximab (Remicade) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200300015/index.html.
-
-
-
-
13
-
-
85031191290
-
-
Omalizumab (Xolair) NDA: Available at the website of PMDA
-
Omalizumab (Xolair) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200900001/index.html.
-
-
-
-
14
-
-
85031190273
-
-
Basiliximab (Simulect) NDA: Available at the website of PMDA
-
Basiliximab (Simulect) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200200005/index.html.
-
-
-
-
15
-
-
85031186207
-
-
Cetuximab (Erbitux) NDA: Available at the website of PMDA
-
Cetuximab (Erbitux) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200800039/index.html.
-
-
-
-
16
-
-
85031182099
-
-
Palivizumab (Synagis) NDA: Available at the website of PMDA
-
Palivizumab (Synagis) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200200010/index.html.
-
-
-
-
17
-
-
85031191579
-
-
Rituximab (Rituxan) NDA: Available at the website of PMDA
-
Rituximab (Rituxan) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200100018/index.html.
-
-
-
-
18
-
-
85031180321
-
-
Tocilizumab (Actemra) NDA: Available at the website of PMDA
-
Tocilizumab (Actemra) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200500016/index.html.
-
-
-
-
19
-
-
85031182568
-
-
Trastuzumab (Herceptin) NDA: Available at the website of PMDA
-
Trastuzumab (Herceptin) NDA: Available at the website of PMDA: http://www.info.pmda.go.jp/shinyaku/P200100003/index.html.
-
-
-
|